Webinar description:

What risks does RbM intro­duce by itself? Why mon­i­tor­ing team does not accept the new RbM pro­ce­dure? How should sites be involved in RbM process?
Now, we can tackle these questions.

We are going to review the def­i­n­i­tion of Risk-based Mon­i­tor­ing (RbM) in clin­i­cal research. Dif­fer­ence of def­i­n­i­tions between FDA and EMA?

Answer “What it’s in it for me?” ques­tion. — Share real-life exam­ples of the RbM appli­ca­tion.
Iden­tify the dif­fi­cul­ties & poten­tial pit­falls of RbM application.In our webi­nar, we will devote our atten­tion to prac­ti­cal insights of imple­men­ta­tion risk-based mon­i­tor­ing strat­egy and appli­ca­tion of inno­v­a­tive soft­ware projects in this domain — con­trolled risks are man­age­able risks.